Error: Could not add to watchlist. X

Medite Cancer Diagnostics Inc

+ Watchlist
CYOE:US
Ticker Change
CYOE:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Medical Equipment & Devices
Sub-Industry
Life Science Equipment

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Medite Cancer Diagnostics Inc develops a proteomic-based method of screening and diagnosis for endometrial and cervical cancer. The Company's products assist in the early detection of cervical, gastrointestinal, and other cancers. Medite's products include the InPath System cervical cancer screening system.
ADDRESS
414 North Orleans Street
Suite 510
Chicago, IL 60654
United States
PHONE
1-312-222-9550
  • Robert F McCullough
    Chairman/CFO/Investor Relations
  • Michaela Ott
    Chief Executive Officer
  • Michael Ott
    President/COO
Show More